Journals / Journal of Clinical Research in Pediatric Endocrinology / 2016 / Cilt: 8 - Sayı: 2

A Novel Mutation in Human Androgen Receptor Gene Causing Partial Androgen Insensitivity Syndrome in a Patient Presenting with Gynecomastia at Puberty

Pages
232–235
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

An accurate approach including a detailed family history suggesting an X-linked trait is an important clue for a quick diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Partial androgen insensitivity syndrome (PAIS) typically presents with micropenis, perineoscrotal hypospadias, and a bifid scrotum with descending or undescending testes and gynecomastia at puberty.
📊
Key Findings & Data:A 16-year-old boy was admitted with complaints of gynecomastia and sparse facial hair.
💡
Conclusion & Impact:An accurate approach including a detailed family history suggesting an X-linked trait is an important clue for a quick diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Partial androgen insensitivity syndrome (PAIS) typically presents with micropenis, perineoscrotal hypospadias, and a bifid scrotum with descending or undescending testes and gynecomastia at puberty. It is an X-linked recessive disorder resulting from mutations in the androgen receptor (AR) gene. However, AR gene mutations are found in less than a third of PAIS cases. A 16-year-old boy was admitted with complaints of gynecomastia and sparse facial hair. Family history revealed male relatives from maternal side with similar clinical phenotype. His external genitalia were phenotypically male with pubic hair Tanner stage IV, penoscrotal hypospadias, and a bifid scrotum with bilateral atrophic testes. He had elevated gonadotropins with a normal testosterone level. Chromosome analysis revealed a 46,XY karyotype. Due to the family history suggesting a disorder of X-linked trait, PAIS was considered and molecular analysis of AR gene was performed. DNA sequence analysis revealed a novel hemizygous mutation p.T576I (c.1727C>T) in the AR gene. The diagnosis of PAIS is based upon clinical phenotype and laboratory findings and can be confirmed by detection of a defect in the AR gene. An accurate approach including a detailed family history suggesting an X-linked trait is an important clue for a quick diagnosis.

🔖

Cite This Article

KOÇYİĞİT, C., SARITAŞ, S., ÇATLI, G., ONAY, H., DÜNDAR, B. N. (2016). A Novel Mutation in Human Androgen Receptor Gene Causing Partial Androgen Insensitivity Syndrome in a Patient Presenting with Gynecomastia at Puberty. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 8 - Sayı: 2, 232–235. https://ajindex.com/articles/214980

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Petroli RJ, Maciel-Guerra AT, Soardi FC, de Calais FL, GuerraJunior G, de Mello MP. Severe forms of partial androgen insensitivity syndrome due to p.L830F novel mutation in androgen receptor gene in a Brazilian family. BMC Res Notes 2011;4:173
  2. Boehmer AL, Brinkmann O, Brüggenwirth H, van Assendelft C, Otten BJ, Verleun-Mooijman MC, Niermeijer MF, Brunner HG, Rouwé CW, Waelkens JJ, Oostdijk W, Kleijer WJ, van der Kwast TH, de Vroede MA, Drop SL. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 2001;86:4151-4160
  3. Spătaru R, Costea G, Spiridon L, Procopiuc C, Dumitriu N, Sirbu DG, Sirbu A, Ivanov M, Dan I. Partial androgen insensitivity syndrome. Multidisciplinary approach - genetic, endocrinological, surgical, psychological, psychiatric, social, ethical and forensic. Rom J Leg Med 2013;21:201-206
  4. Goglia U, Vinanzi C, Zuccarello D, Malpassi D, Ameri P, Casu M, Minuto F, Foresta C, Ferone D. Identification of a novel mutation in exon 1 of androgen receptor gene in an azoospermic patient with mild androgen insensitivity syndrome: case report and literature review. Fertil Steril 2011;96:1165-1169. Epub 2011 Sep 29 5. Ahmed SF, Achermann JC, Arlt W, Balen AH, Conway G, Edwards ZL, Elford S, Hughes IA, Izatt L, Krone N, Miles HL, O’Toole S, Perry L, Sanders C, Simmonds M, Wallace AM, Watt A, Willis D. UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development. Clin Endocrinol (Oxf) 2011;75:12-26
  5. Hughes IA, Deeb A. Androgen resistance. Best Pract Res Clin Endocrinol Metab 2006;20:577-598
  6. Mendoza N, Motos MA. Androgen insensitivity syndrome. Gynecol Endocrinol 2013;29:1-5. Epub 2012 Jul 20 8. Carillo AA, Damian M, Berkovitz G. Disorders of Sexual Differentiation. In: Lifshitz F (ed). Pediatric Endocrinology, Fifth Edition. New York, Informa Healthcare, 2007;365-391
  7. Ahmed SF, Keir L, McNeilly J, Galloway P, O’Toole S, Wallace AM. The concordance between serum anti-Mullerian hormone and testosterone concentrations depends on duration of hCG stimulation in boys undergoing investigation of gonadal function. Clin Endocrinol (Oxf) 2010;72:814-819. Epub 2009 Oct 7 10. Aksglaede L, Sørensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM, Skakkebæk NE, Juul A. Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the